Ebola and Marburg haemorrhagic fever viruses: major scientific advances, but a relatively minor public health threat for Africa.

No abstract is available for this paper.

• Publication year

  2011

• Venue

  Clinical Microbiology and Infection

• Publication date

  2011-07-01

• Fields of study

  Medicine, Environmental Science

• Identifiers
  DOI 10.1111/j.1469-0691.2011.03535.xPMID 21722250
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Ebolavirus Proteins Suppress the Effects of Small Interfering RNA by Direct Interaction with the Mammalian RNA Interference Pathway

  2011cited by this paper
• Evidence for Ebola Virus Superantigen Activity

  2011cited by this paper
• Ebola haemorrhagic fever.

  2011cited by this paper
• Association of KIR2DS1 and KIR2DS3 with fatal outcome in Ebola virus infection

  2010cited by this paper
• High Prevalence of Both Humoral and Cellular Immunity to Zaire ebolavirus among Rural Populations in Gabon

  2010cited by this paper
• Advanced antisense therapies for postexposure protection against lethal filovirus infections

  2010cited by this paper
• Demonstration of Cross-Protective Vaccine Immunity against an Emerging Pathogenic Ebolavirus Species

  2010cited by this paper
• Ebola and marburg hemorrhagic fever.

  2010cited by this paper
• Postexposure protection of non-human primates against a lethal Ebola virus challenge with RNA interference: a proof-of-concept study

  2010cited by this paper
• Mutations Abrogating VP35 Interaction with Double-Stranded RNA Render Ebola Virus Avirulent in Guinea Pigs

  2010cited by this paper
• Antiviral Activity of a Small-Molecule Inhibitor of Filovirus Infection

  2010cited by this paper
• Protection of Nonhuman Primates against Two Species of Ebola Virus Infection with a Single Complex Adenovirus Vector

  2010cited by this paper
• Human Fatal Zaire Ebola Virus Infection Is Associated with an Aberrant Innate Immunity and with Massive Lymphocyte Apoptosis

  2010cited by this paper
• The VP35 protein of Ebola virus impairs dendritic cell maturation induced by virus and lipopolysaccharide.

  2010cited by this paper
• Mechanisms and Consequences of Ebolavirus-Induced Lymphocyte Apoptosis

  2009cited by this paper
• Human Ebola Outbreak Resulting from Direct Exposure to Fruit Bats in Luebo, Democratic Republic of Congo, 2007

  2009cited by this paper
• Ebola Virus Protein VP35 Impairs the Function of Interferon Regulatory Factor-Activating Kinases IKKε and TBK-1

  2009cited by this paper
• Discovery of Swine as a Host for the Reston ebolavirus

  2009cited by this paper
• Immunoglobulin G in Ebola Outbreak Survivors, Gabon

  2009cited by this paper
• Single-Injection Vaccine Protects Nonhuman Primates against Infection with Marburg Virus and Three Species of Ebola Virus

  2009cited by this paper
• Isolation of Genetically Diverse Marburg Viruses from Egyptian Fruit Bats

  2009cited by this paper
• Ebola Zaire Virus Blocks Type I Interferon Production by Exploiting the Host SUMO Modification Machinery

  2009cited by this paper
• Filoviruses. A compendium of 40 years of epidemiological, clinical, and laboratory studies.

  2008cited by this paper
• Reference Intervals in Healthy Adult Ugandan Blood Donors and Their Impact on Conducting International Vaccine Trials

  2008cited by this paper
• Whole-Genome Expression Profiling Reveals That Inhibition of Host Innate Immune Response Pathways by Ebola Virus Can Be Reversed by a Single Amino Acid Change in the VP35 Protein

  2008cited by this paper
• Filoviruses: A Compendium of 40 Years of Epidemiological, Clinical, and Laboratory Studies

  2008cited by this paper
• Vaccine To Confer to Nonhuman Primates Complete Protection against Multistrain Ebola and Marburg Virus Infections

  2008cited by this paper
• Recombinant Vesicular Stomatitis Virus Vector Mediates Postexposure Protection against Sudan Ebola Hemorrhagic Fever in Nonhuman Primates

  2008cited by this paper
• Inhibition of IRF-3 Activation by VP35 Is Critical for the High Level of Virulence of Ebola Virus

  2008cited by this paper
• Isolates of Zaire ebolavirus from wild apes reveal genetic lineage and recombinants

  2007cited by this paper
• Marburg hemorrhagic fever in Durba and Watsa, Democratic Republic of the Congo: clinical documentation, features of illness, and treatment.

  2007cited by this paper
• Correction for Wittmann et al., Isolates of Zaire ebolavirus from wild apes reveal genetic lineage and recombinants

  2007cited by this paper
• Filovirus research: knowledge expands to meet a growing threat.

  2007cited by this paper
• Mapping of the VP40-Binding Regions of the Nucleoprotein of Ebola Virus

  2007cited by this paper
• Effective Post-Exposure Treatment of Ebola Infection

  2007cited by this paper
• Successful Topical Respiratory Tract Immunization of Primates against Ebola Virus

  2007cited by this paper
• Prevention of Immune Cell Apoptosis as Potential Therapeutic Strategy for Severe Infections

  2007cited by this paper
• Laboratory diagnosis of Ebola hemorrhagic fever during an outbreak in Yambio, Sudan, 2004.

  2007cited by this paper
• Ebola Virus VP24 Proteins Inhibit the Interaction of NPI-1 Subfamily Karyopherin α Proteins with Activated STAT1

  2007cited by this paper
• Ebola virus-like particle-based vaccine protects nonhuman primates against lethal Ebola virus challenge.

  2007cited by this paper
• Ebola hemorrhagic fever: evaluation of passive immunotherapy in nonhuman primates.

  2007cited by this paper
• Spatial and temporal patterns of Zaire ebolavirus antibody prevalence in the possible reservoir bat species.

  2007cited by this paper
• Studies of Reservoir Hosts for Marburg Virus

  2007cited by this paper
• The Ebola Virus VP35 Protein Is a Suppressor of RNA Silencing

  2007cited by this paper
• Recombinant human activated protein C for the postexposure treatment of Ebola hemorrhagic fever.

  2007cited by this paper
• Forty years of marburg virus.

  2007cited by this paper
• Ebola virus: unravelling pathogenesis to combat a deadly disease.

  2006cited by this paper
• Detection of Ebola virus in oral fluid specimens during outbreaks of Ebola virus hemorrhagic fever in the Republic of Congo.

  2006cited by this paper
• Marburgvirus Genomics and Association with a Large Hemorrhagic Fever Outbreak in Angola

  2006cited by this paper
• Ebola virus VP24 binds karyopherin alpha1 and blocks STAT1 nuclear accumulation.

  2006cited by this paper
• Ebola Virus VP35 Protein Binds Double-Stranded RNA and Inhibits Alpha/Beta Interferon Production Induced by RIG-I Signaling

  2006cited by this paper
• Ebola Virus VP35-VP40 Interaction Is Sufficient for Packaging 3E-5E Minigenome RNA into Virus-Like Particles

  2006cited by this paper
• The VP35 Protein of Ebola Virus Inhibits the Antiviral Effect Mediated by Double-Stranded RNA-Dependent Protein Kinase PKR

  2006cited by this paper
• Ebola Virus VP24 Binds Karyopherin α1 and Blocks STAT1 Nuclear Accumulation

  2006cited by this paper
• Geographic potential for outbreaks of Marburg hemorrhagic fever.

  2006cited by this paper
• Gene-Specific Countermeasures against Ebola Virus Based on Antisense Phosphorodiamidate Morpholino Oligomers

  2006cited by this paper
• Implication of a retrovirus‐like glycoprotein peptide in the immunopathogenesis of Ebola and Marburg viruses

  2006cited by this paper
• Ebola Outbreak Killed 5000 Gorillas

  2006cited by this paper
• Marburg hemorrhagic fever associated with multiple genetic lineages of virus.

  2006cited by this paper
• Wild Animal Mortality Monitoring and Human Ebola Outbreaks, Gabon and Republic of Congo, 2001–2003

  2005cited by this paper
• Complete genome sequence of an Ebola virus (Sudan species) responsible for a 2000 outbreak of human disease in Uganda.

  2005cited by this paper
• The natural history of Ebola virus in Africa.

  2005cited by this paper
• VP24 of Marburg Virus Influences Formation of Infectious Particles

  2005cited by this paper
• Live attenuated recombinant vaccine protects nonhuman primates against Ebola and Marburg viruses

  2005cited by this paper
• Fruit bats as reservoirs of Ebola virus

  2005cited by this paper
• Rapid Diagnosis of Ebola Hemorrhagic Fever by Reverse Transcription-PCR in an Outbreak Setting and Assessment of Patient Viral Load as a Predictor of Outcome

  2004cited by this paper
• Potential Mammalian Filovirus Reservoirs

  2004cited by this paper
• Multiple Ebola Virus Transmission Events and Rapid Decline of Central African Wildlife

  2004influential reference
• Containing a haemorrhagic fever epidemic: the Ebola experience in Uganda (October 2000-January 2001).

  2004cited by this paper
• A C-terminal basic amino acid motif of Zaire ebolavirus VP35 is essential for type I interferon antagonism and displays high identity with the RNA-binding domain of another interferon antagonist, the NS1 protein of influenza A virus.

  2004cited by this paper
• Emerging roles of tissue factor in viral hemorrhagic fever.

  2004cited by this paper
• Ecologic and Geographic Distribution of Filovirus Disease

  2004cited by this paper
• Ectodomain shedding of the glycoprotein GP of Ebola virus

  2004cited by this paper
• Production of Novel Ebola Virus-Like Particles from cDNAs: an Alternative to Ebola Virus Generation by Reverse Genetics

  2004cited by this paper
• Ebola haemorrhagic fever--fact sheet revised in May 2004.

  2004cited by this paper
• Depletion of Peripheral Blood T Lymphocytes and NK Cells During the Course of Ebola Hemorrhagic Fever in Cynomolgus Macaques

  2004cited by this paper
• A serological survey of Ebola virus infection in central African nonhuman primates.

  2004cited by this paper
• Trigger events: enviroclimatic coupling of Ebola hemorrhagic fever outbreaks.

  2004cited by this paper
• Ebola virus ecology: a continuing mystery.

  2004cited by this paper
• Pathogenesis of Ebola hemorrhagic fever in primate models: evidence that hemorrhage is not a direct effect of virus-induced cytolysis of endothelial cells.

  2003cited by this paper
• Biochemical and Functional Characterization of the Ebola Virus VP24 Protein: Implications for a Role in Virus Assembly and Budding

  2003cited by this paper
• The Ebola Virus VP35 Protein Inhibits Activation of Interferon Regulatory Factor 3

  2003cited by this paper
• Treatment of Ebola virus infection with a recombinant inhibitor of factor VIIa/tissue factor: a study in rhesus monkeys.

  2003cited by this paper
• Ebola and Marburg viruses replicate in monocyte-derived dendritic cells without inducing the production of cytokines and full maturation.

  2003cited by this paper
• Pathogenesis of Ebola hemorrhagic fever in cynomolgus macaques: evidence that dendritic cells are early and sustained targets of infection.

  2003cited by this paper
• Accelerated vaccination for Ebola virus haemorrhagic fever in non-human primates

  2003cited by this paper
• Risk Factors for Marburg Hemorrhagic Fever, Democratic Republic of the Congo

  2003cited by this paper
• Ebola and the decline of gorilla Gorilla gorilla and chimpanzee Pan troglodytes populations in Minkebe Forest, north-eastern Gabon

  2003cited by this paper
• Mechanisms underlying coagulation abnormalities in ebola hemorrhagic fever: overexpression of tissue factor in primate monocytes/macrophages is a key event.

  2003cited by this paper
• Catastrophic ape decline in western equatorial Africa

  2003cited by this paper
• Cutting Edge: Impairment of Dendritic Cells and Adaptive Immunity by Ebola and Lassa Viruses1

  2003cited by this paper
• Proinflammatory response during Ebola virus infection of primate models: possible involvement of the tumor necrosis factor receptor superfamily.

  2002cited by this paper
• Sequence analysis of the GP, NP, VP40 and VP24 genes of Ebola virus isolated from deceased, surviving and asymptomatically infected individuals during the 1996 outbreak in Gabon: comparative studies and phylogenetic characterization.

  2002cited by this paper
• Evidence against an important role for infectivity-enhancing antibodies in Ebola virus infections.

  2002cited by this paper
• An outbreak of Ebola in Uganda

  2002cited by this paper
• The assembly of Ebola virus nucleocapsid requires virion-associated proteins 35 and 24 and posttranslational modification of nucleoprotein.

  2002cited by this paper
• Inflammatory responses in Ebola virus‐infected patients

  2002cited by this paper
• Re-emergence of ebola haemorrhagic fever in Gabon.

  2002cited by this paper
• Ebola Virus VP40 Drives the Formation of Virus-Like Filamentous Particles Along with GP

  2002cited by this paper
• Hemorrhagic fever viruses as biological weapons: medical and public health management.

  2002cited by this paper

• The Antiviral Activity of Polyphenols

  2025cites this paper
• Interferons Inhibit Ebola Virus Infection of Human Keratinocytes

  2025cites this paper
• Acute malaria dysregulates specialized lymph node macrophages to suppress vaccine-elicited protection against the Ebola virus

  2025cites this paper
• Ebola Virus Disease: Uniquely Challenging Among the Viral Hemorrhagic Fevers

  2025cites this paper
• Exploring plant-derived small molecules as inhibitors of Marburg virus RNA binding protein activity

  2024cites this paper
• Post-Traumatic Psychological Experience of COVID-19 Survivors: A Descriptive Phenomenological Study

  2024cites this paper
• Cheminformatics-based analysis identified (Z)-2-(2,5-dimethoxy benzylidene)-6-(2-(4-methoxyphenyl)-2-oxoethoxy) benzofuran-3(2H)-one as an inhibitor of Marburg replication by interacting with NP.

  2024cites this paper
• Stamping out Marburg virus disease in Tanzania: cutting-edge interventions and recommendations for a healthier future

  2023cites this paper
• Marburg virus disease: the paradox of Nigeria’s preparedness and priority effects in co-epidemics

  2023cites this paper
• Applications and advances in acoustic monitoring for infectious disease epidemiology.

  2023cites this paper
• Exploring Alternative Care Platforms for Symptomatic People in the Fight against the Ebola Virus Disease Outbreak

  2023cites this paper
• A review of Gabonese gorillas and their pathogens: Diversity, transfer and One Health approach to avoid future outbreaks?

  2023cites this paper
• How to do things with insecure extensions

  2023cites this paper
• Reemergence of Marburgvirus disease: Update on current control and prevention measures and review of the literature

  2023cites this paper
• Economic Impact of the Western Africa Ebola Outbreak - A Holistic Approach

  2022cites this paper
• Pathogenicity and virulence of Marburg virus

  2022cites this paper
• Scientific Consensus, Doctrinal Paradox and Discursive Dilemma

  2022cites this paper
• Perspectives on the Use of Small Noncoding RNAs as a Therapy for Severe Virus-Induced Disease Manifestations and Late Complications

  2022cites this paper
• Great ape health watch: Enhancing surveillance for emerging infectious diseases in great apes

  2022cites this paper
• Structural insights into the interactions between lloviu virus VP30 and nucleoprotein.

  2022cites this paper
• [Epidemiology of Viral Hemorrhagic Fever in Africa].

  2021cites this paper
• Lipid-specific oligomerization of the Marburg virus matrix protein VP40 is regulated by two distinct interfaces for virion assembly

  2021cites this paper
• Simultaneous Detection of Ebola Virus and Pathogens Associated With Hemorrhagic Fever by an Oligonucleotide Microarray

  2021cites this paper
• Genome structure and genetic diversity in the Ebola virus.

  2021cites this paper
• Cross-Neutralisation of Novel Bombali Virus by Ebola Virus Antibodies and Convalescent Plasma Using an Optimised Pseudotype-Based Neutralisation Assay

  2021cites this paper
• Viral Zoonoses: Wildlife Perspectives

  2020cites this paper
• Examining the Role of Niemann-Pick C1 Protein in the Permissiveness of Aedes Mosquitoes to Filoviruses.

  2020cites this paper
• Animal-Origin Viral Zoonoses

  2020cites this paper
• Virale hämorrhagische Fieber

  2020cites this paper
• Identifying Suspect Bat Reservoirs of Emerging Infections

  2020cites this paper
• Novel frontiers on ebola virus disease management: An update

  2020cites this paper
• Lipid-specific protein oligomerization is regulated by two interfaces in Marburg virus matrix protein VP40

  2020cites this paper
• Delayed recognition of Ebola virus disease is associated with longer and larger outbreaks

  2020cites this paper
• Emerging Zoonotic Diseases: Should We Rethink the Animal–Human Interface?

  2020cites this paper
• The induction and characterization of monoclonal antibodies specific to GP of Ebola virus

  2020cites this paper
• Modelling the daily risk of Ebola in the presence and absence of a potential vaccine

  2020cites this paper
• Ebola Virus Disease

  2019cites this paper
• Dendritic Cells/Macrophages-Targeting Feature of Ebola Glycoprotein and its Potential as Immunological Facilitator for Antiviral Vaccine Approach

  2019cites this paper
• Epidemiological Trends and Current Challenges in Ebola: Pathogen Biology, Drug Targets, and Therapeutic Strategies

  2019cites this paper
• Prevalence of Ebola Virus Disease and Its Effect in Social Interaction in the Nation

  2019cites this paper
• Virale hämorrhagische Fieber bei Kindern und Jugendlichen

  2019cites this paper
• A simulation investigation on interaction mechanism between Ebola nucleoprotein and VP35 peptide

  2018cites this paper
• Naturally Occurring Single Mutations in Ebola Virus Observably Impact Infectivity

  2018influential citation
• A Fuzzy Logic Expert System for Diagnosing EHF and Evaluating its Risk Level

  2018cites this paper
• Rare and Emerging Viral Infections in the Transplant Population

  2018cites this paper
• Sending the Right Message: Wild Game and the West Africa Ebola Outbreak

  2018cites this paper
• Distinct Immunogenicity and Efficacy of Poxvirus-Based Vaccine Candidates against Ebola Virus Expressing GP and VP40 Proteins

  2018cites this paper
• EBOLA VIRUS DISEASE AND ZIKA VIRUS DISEASE: NEUROPSYCHIATRIC SEQUELAE

  2017cites this paper
• Correction: Correction: A Novel Rhabdovirus Associated with Acute Hemorrhagic Fever in Central Africa

  2017cites this paper
• Curcumin and Natural Derivatives Inhibit Ebola Viral Proteins: An In silico Approach

  2017cites this paper
• Global Spread of Hemorrhagic Fever Viruses: Predicting Pandemics

  2017cites this paper
• Coping With the Threat of Ebola in Monrovia: A Case Study

  2017influential citation
• Contrasting academic and lay press print coverage of the 2013-2016 Ebola Virus Disease outbreak

  2017cites this paper
• A Historical Review of Ebola Outbreaks

  2017cites this paper
• Ebola Hemorrhagic Fever: Recent Update On Disease Status, Current Therapies And Advances In Treatment

  2017cites this paper
• Ebola Virus Disease: Biology, Diagnosis, Treatment and Prevention of Epidemics

  2017cites this paper
• Deep-sequencing of Marburg virus genome during sequential mouse passaging and cell-culture adaptation reveals extensive changes over time

  2017cites this paper
• Ebola virus disease: Essential clinical knowledge

  2017cites this paper
• Counterproductive contributions to African epidemiology

  2017cites this paper
• Transmission or Within-Host Dynamics Driving Pulses of Zoonotic Viruses in Reservoir–Host Populations

  2016cites this paper
• Virus fitness differences observed between two naturally occurring isolates of Ebola virus Makona variant using a reverse genetics approach.

  2016cites this paper
• Pathogenicity Comparison Between the Kikwit and Makona Ebola Virus Variants in Rhesus Macaques.

  2016cites this paper
• Viral Zoonoses That Fly with Bats: A Review

  2016cites this paper
• Chinese Public Attention to the Outbreak of Ebola in West Africa: Evidence from the Online Big Data Platform

  2016cites this paper
• Prognostic Indicators for Ebola Patient Survival

  2016cites this paper
• Meat from the wild: extractive uses of wildlife and alternatives for sustainability

  2016cites this paper
• The Role of the Laboratory and Transfusion Service in the Management of Ebola Virus Disease☆☆☆

  2016cites this paper
• Les fièvres hémorragiques virales

  2016cites this paper
• Ebola virus in West Africa: new conquered territories and new risks-or how I learned to stop worrying and (not) love Ebola virus.

  2015cites this paper
• Ecological dynamics of emerging bat virus spillover

  2015cites this paper
• Ebola virus disease in nonendemic countries

  2015cites this paper
• Ebola outbreak 2013-2014: a rational examination for the clinical nurse specialist.

  2015cites this paper
• Ebola Virus Entry into Host Cells: Identifying Therapeutic Strategies

  2015cites this paper
• OUTBREAK RESPONSE

  2015cites this paper
• Interferon-γ Inhibits Ebola Virus Infection

  2015cites this paper
• Effective Binding of a Phosphatidylserine-Targeting Antibody to Ebola Virus Infected Cells and Purified Virions

  2015cites this paper
• Genetic identification of cytomegaloviruses in a rural population of Côte d’Ivoire

  2015cites this paper
• EBOLA HAEMORRHAGIC FEVER VIRUS

  2015cites this paper
• Living Under the Constant Threat of Ebola: A Phenomenological Study of Survivors and Family Caregivers During an Ebola Outbreak

  2015cites this paper
• Ebola Virus Disease

  2015cites this paper
• Ebola: a review for emergency providers.

  2015cites this paper
• Ebola hemorrhagic fever outbreaks: strategies for effective epidemic management, containment and control

  2015cites this paper
• Mechanism of Binding to Ebola Virus Glycoprotein by the ZMapp, ZMAb, and MB-003 Cocktail Antibodies

  2015influential citation
• Ebola Virus Disease: History, Epidemiology and Outbreaks

  2015cites this paper
• Selected aspects of filoviruses in the view of Ebola virus disease epidemic.

  2015cites this paper
• CMI editorial report, 2015.

  2015cites this paper
• Ebolavirus and Haemorrhagic Syndrome.

  2015cites this paper
• How the current West African Ebola virus disease epidemic is altering views on the need for vaccines and is galvanizing a global effort to field-test leading candidate vaccines.

  2015cites this paper
• EBOLA VIRUS DISEASE POWERED BY THOMSON REUTERS CORTELLIS TM

  2015cites this paper
• Post-Traumatic Stress Reactions in Ebola Virus Disease Survivors in SierraLeone

  2015cites this paper
• Sex, Gender, and Hemorrhagic Fever Viruses

  2015cites this paper
• Ebola virus – current threats and perspectives for control of infections

  2015influential citation
• Virale Infektionen bei Kindern und Jugendlichen: DNA-Viren

  2015cites this paper
• Ebola virus: entry, pathogenesis and identification of host antiviral activities

  2015cites this paper
• Charakterisierung der RNA-Bindungsaktivität von VP30 im Hinblick auf die virale Transkriptionsregulation des Ebolavirus

  2015cites this paper
• The Ebola Virus Disease Outbreak in Guinea, Liberia and Sierra Leone - Data Management Implementation and Outcomes for Movement and Monitoring of Travelers at Points of Entry

  2015cites this paper
• EBOLA, SEQUER UMA DOENÇA TROPICAL NEGLIGENCIADA

  2015cites this paper
• L’Émergence du virus EBOLA chez l’homme: un long processus pas totalement élucidé

  2015cites this paper
• Development of a reverse genetics system to generate a recombinant Ebola virus Makona expressing a green fluorescent protein.

  2015cites this paper
• Post-Traumatic Stress Reactions in Ebola Virus Disease Survivors in Sierra Leone

  2015cites this paper